In the NDV-MIP3α treated B16 and CT26 tumour-bearing mice successful attraction of DCs and significant reversion of immunosuppressive tumour microenvironment induced production of tumour-specific cellular and humoral immune responses, which was dependent on CD8+ T cells and partially on CD4+ T cells [180]. The gene discussed is CD8A; the disease is neoplasm.